Your browser doesn't support javascript.
loading
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
Im, Young-Hyuck; Karabulut, Bulent; Lee, Keun Seok; Park, Byeong-Woo; Adhav, Aditya; Cinkir, Havva Yesil; Abdel-Razeq, Hikmat; Chang, Yuan-Ching; Aksoy, Sercan; Im, Seock-Ah; Jeong, Joon; Chae, Yeesoo; Bowles, James; Slimane, Khemaies; Xue, Hongling; Kim, Sung-Bae.
Affiliation
  • Im YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. imyh00@skku.edu.
  • Karabulut B; Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Lee KS; Center for Breast Cancer, National Cancer Center, Gyeonggi do, Korea.
  • Park BW; Department of Surgery, Yonsei University Health System, Severance Hospital, Seoul, Korea.
  • Adhav A; Department of Surgical Oncology, HCG Manavata Cancer Centre, Nashik, India.
  • Cinkir HY; Department of Medical Oncology, Gaziantep University Medical Faculty, Gaziantep, Turkey.
  • Abdel-Razeq H; King Hussein Cancer Center, Amman, Jordan.
  • Chang YC; Mackay Memorial Hospital, Taipei, Taiwan.
  • Aksoy S; Hacettepe University Medical Faculty, Ankara, Turkey.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Jeong J; Department of Surgery, Gangnam Severance Hospital Yonsei University Health System, Seoul, Korea.
  • Chae Y; Kyungpook National University Hospital, Daegu, Korea.
  • Bowles J; Novartis Pharma AG, Basel, Switzerland.
  • Slimane K; Novartis Pharma AG, Basel, Switzerland.
  • Xue H; Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore, Singapore.
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Breast Cancer Res Treat ; 188(1): 77-89, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33728524

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Everolimus Limits: Female / Humans Country/Region as subject: Asia Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Everolimus Limits: Female / Humans Country/Region as subject: Asia Language: En Year: 2021 Type: Article